Sussex Partner Formulary

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Ethinylestradiol + Desogestrel

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Currently Bimizza (150microgram/20microgram) and Cimizt (30microgram/150microgram) are the most cost-effective tablets

Ethinylestradiol 20microgram / Desogestrel 150microgram tablets

Pack
63 tablet

Ethinylestradiol 30microgram / Desogestrel 150microgram tablets

Pack
63 tablet

Ethinylestradiol + Drospirenone

{ Value = MHRA Warning Exists, Index = 4 } { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Currently Yacella and Yiznell are the most cost-effective tablets.

Ethinylestradiol 20microgram / Drospirenone 3mg tablets

Pack
84 tablet

Ethinylestradiol 30microgram / Drospirenone 3mg tablets

Pack
63 tablet
21 tablet

Ethinylestradiol + Etonogestrel

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Currently SyreniRing is the most cost-effective vaginal delivery system

Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system

Pack
3 system

Ethinylestradiol + Gestodene

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Ethinylestradiol + Levonorgestrel

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Ethinylestradiol + Norelgestromin

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Ethinylestradiol + Norethisterone

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Ethinylestradiol + Norgestimate

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }